BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matsumoto R, Arigami T, Matsushita D, Okubo K, Tanaka T, Yanagita S, Sasaki K, Noda M, Kita Y, Mori S, Kurahara H, Ohtsuka T. Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report. World J Surg Oncol 2020;18:179. [PMID: 32693806 DOI: 10.1186/s12957-020-01954-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Jian D, Qian C, Wang D, Ma Q, Wang L, Li C, Xu M, Dai N, Chen Q, He J, Zhang H, Yuan M, Chen R, Chao R, Feng Y. Conversion therapy with tislelizumab for high microsatellite instability, unresectable stage III gastric cancer: a case report. Ann Transl Med 2021;9:1489. [PMID: 34734041 DOI: 10.21037/atm-21-4295] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Toyota Y, Okamoto K, Tanaka N, Colvin HS, Takahashi Y, Inaba T. Conversion surgery of Stage IV gastric cancer with peritoneal dissemination after nivolumab. Int Cancer Conf J 2021;10:280-4. [PMID: 34567938 DOI: 10.1007/s13691-021-00503-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kumamoto T, Tomita T, Hojo Y, Nakamura T, Kurahashi Y, Ishida Y, Miwa H, Hirota S, Shinohara H. Pathological Complete Response and Successful Conversion Surgery After Nivolumab Therapy for Stage IV Oesophagogastric Junction Cancer. In Vivo 2021;35:2247-51. [PMID: 34182503 DOI: 10.21873/invivo.12497] [Reference Citation Analysis]
4 Suzuki M, Hosaka H, Fukai Y, Mochida Y, Ozawa D, Kogure N, Yamada K, Ojima H. Conversion surgery for metastatic gastric cancer at 2 years after initial diagnosis of cancer of unknown primary with metastasis of cervical lymph nodes and ovary: a case report. Surg Case Rep 2021;7:62. [PMID: 33665675 DOI: 10.1186/s40792-021-01145-3] [Reference Citation Analysis]
5 Watanabe H, Fujikawa H, Komori K, Kano K, Takahashi K, Yamada T, Inokuchi Y, Machida N, Yokose T, Rino Y, Masuda M, Ogata T, Oshima T. Successful Conversion Surgery for Stage IV Gastric Cancer after Nivolumab Monotherapy as Third-Line Chemotherapy. Case Rep Gastroenterol 2021;15:562-7. [PMID: 34616257 DOI: 10.1159/000514396] [Reference Citation Analysis]
6 Toyota S, Naito H, Motoyoshi S, Nakanishi R, Oki E, Orita H, Korenaga D. Extended total gastrectomy after nivolumab for unresectable multivisceral invasive gastric cancer. Surg Case Rep 2020;6:298. [PMID: 33237443 DOI: 10.1186/s40792-020-01040-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Namikawa T, Marui A, Yokota K, Fujieda Y, Munekage M, Uemura S, Maeda H, Kitagawa H, Kobayashi M, Hanazaki K. Successful Conversion Surgery for Advanced Gastric Cancer With Multiple Liver Metastases Following Ramucirumab Plus Paclitaxel Combination Treatment. In Vivo 2021;35:2929-35. [PMID: 34410989 DOI: 10.21873/invivo.12584] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]